Covington convened our annual Boston Life Sciences Symposium to examine how the life sciences industry is navigating rapid change across regulation, enforcement, transactions, and policy. Learn more: https://t.co/3umeVcSnkV
This alert summarizes trends and otherwise notable allegations in publicly available FDA warning letters relating to medical devices, issued in the first quarter of 2026: https://t.co/lMY7UYX6tD
The SEC’s proposed changes to public company filer status categories would extend current scaled disclosure, five-year on ramp and other accommodations to most public companies. Read how these amendments would affect you: https://t.co/FwT8T1k1Eb
The SEC has proposed significant and wide-ranging amendments to its registered securities offering framework that could fundamentally change how public companies raise capital. Read our alert: https://t.co/wuGFFTjcNN
The European Commission has published draft guidelines on the implementation of the transparency obligations under Article 50 of the EU AI Act,” opening a targeted consultation that runs until June 3, 2026. We summarize 10 takeaways: https://t.co/PtLUq85maW
The UK Government has memorialized its agreement with the U.S. on pharmaceutical pricing. This blog discusses the published text and the potential impact for the pharmaceutical industry more broadly: https://t.co/X4lQMPYDnb
Read our new post: Today’s Press Release Could Be Tomorrow’s Subpoena: Bracing For the Possibility of Democratic Congressional Investigations https://t.co/J9jM4FZhP4
Join our Fifth Annual Robotics Forum, “Physical AI: Opportunities, Risks, and the Path Through Regulation,” to hear from our lawyers on the key issues impacting companies developing or using physical AI technologies or operating in the robotics space: https://t.co/iBcuDGJGkg
This alert summarizes publicly available FDA enforcement letters relating to the advertising and promotion of prescription drugs, medical devices, and biologics, issued during the first quarter of 2026: https://t.co/miNkryI5fE
Join our Fifth Annual Robotics Forum, “Physical AI: Opportunities, Risks, and the Path Through Regulation.” Find out more and register here: https://t.co/l3WKoN9WSY
In the latest installment of our Women in Securities series, our lawyers highlight a new SEC order permitting tender offers to remain open for a minimum of 10 business days rather than the standard 20. Read our full client alert to learn more: https://t.co/8E4zaPVjUf
Clients choose Covington because we bring clarity to complexity in the increasingly demanding datacenter market. Our Datacenter Insights Hub provides practical and actionable insights for developers, operators, investors, and hyperscalers: https://t.co/gfbYVxXqEm
The U.S. Department of the Treasury’s Financial Crimes Enforcement Network has published a Notice of Proposed Rulemaking that would, if finalized, establish procedures for FinCEN’s whistleblower program. Here are the five things to know: https://t.co/rj2wXcEZxM
The European Chemicals Agency has published a draft opinion of its Socio-Economic Assessment Committee on the proposed universal ban of per- and polyfluoroalkyl substances under the EU REACH Regulation. This alert discusses the draft and the next steps: https://t.co/Aetfow7Jgx
As #AI technologies continue to advance and states increasingly pass legislation to regulate AI development and use, Congress and the White House are proposing comprehensive nationwide laws. We discuss them in this blog: https://t.co/WT2pmegX8J
Exclusive: Russia have used chess as propaganda for decades — but a landmark CAS decision, released earlier, challenges their claim over Ukraine.
Russia must stop organising chess in occupied territories — or be banned from the sport they hold dearest.
https://t.co/3jk4aHslKd
The U.S Court of Appeals for the Fifth Circuit has denied the FTC's motion to stay an earlier decision that vacated the revised HSR rules. Read more: https://t.co/m8b4i8MOdg